Related Experiment Video
Updated: Jul 7, 2025

05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
2.9K
Balloon pulmonary valvuloplasty: A systematic review.
1Children's Heart Institute, University of Texas-Houston McGovern Medical School, Children's Memorial Hermann Hospital, Houston, TX, USA.
Indian Heart Journal
|December 26, 2023
Summary
Balloon pulmonary valvuloplasty (BPV) effectively relieves pulmonary valve obstruction. However, recurrent stenosis may occur, necessitating repeat BPV, and long-term pulmonary insufficiency may require valve replacement.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Interventional Cardiology
Background:
- Pulmonary stenosis (PS) is a significant congenital heart defect.
- Balloon pulmonary valvuloplasty (BPV) is a primary intervention for valvar PS.
- Understanding factors influencing BPV outcomes is crucial for patient management.
Approach:
- Review of evidence on immediate and long-term outcomes of BPV.
- Analysis of factors contributing to recurrent pulmonary stenosis.
- Evaluation of strategies to mitigate long-term complications like pulmonary insufficiency.
Key Points:
- BPV provides immediate and sustained relief of pulmonary valve obstruction.
- Infundibular obstruction may develop in severe PS cases or older patients.
- Recurrent stenosis occurs in ~10% of patients, linked to low balloon/annulus ratio and high post-BPV gradients.
- Repeat BPV with larger balloons can address recurrent stenosis.
- Long-term follow-up reveals pulmonary insufficiency in some patients, potentially requiring valve replacement.
Conclusions:
- BPV is the preferred treatment for valvar PS.
- Optimizing the balloon/annulus ratio to 1.2-1.25 is recommended.
- Developing strategies to prevent or reduce long-term pulmonary insufficiency is essential.
Keywords:
Balloon pulmonary valvuloplastyLong-term resultsPulmonary insufficiencyPulmonary stenosisRestenosis
